Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer.

Dieci MV, Conte P, Bisagni G, Brandes AA, Frassoldati A, Cavanna L, Musolino A, Giotta F, Rimanti A, Garrone O, Bertone E, Cagossi K, Sarti S, Ferro A, Piacentini F, Maiorana A, Orvieto E, Sanders M, Miglietta F, Balduzzi S, D'Amico R, Guarneri V
Ann Oncol. 2019 30 (3): 418-423

PMID: 30657852 · PMCID: PMC6442655 · DOI:10.1093/annonc/mdz007

MeSH Terms (16)

Adult Aged Antineoplastic Combined Chemotherapy Protocols Breast Neoplasms Chemotherapy, Adjuvant Disease-Free Survival Drug-Related Side Effects and Adverse Reactions Female Humans Kaplan-Meier Estimate Lymphocytes, Tumor-Infiltrating Middle Aged Neoplasm Recurrence, Local Receptor, ErbB-2 Trastuzumab Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities:

Links